The markets traded mixed during the midday with the Dow losing 33 points to 16,296 as crude oil prices retreated while gold and silver rose. Nasdaq added 6 points to 4,763.
On the upside
Bloomberg reported that BioMed Realty Trust (NYSE: BMR) was in the process of selling itself.
Shares of Conatus Pharmaceuticals (Nasdaq: CNAT) continued rising.
Concert Pharmaceuticals (Nasdaq: CNCE) reported positive data from a Phase 1 clinical trial of CTP-656.
On the downside
Rumors circulated that Verizon Communications (NYSE: VZ) may stop using Synchronoss Technologies’ (Nasdaq: SNCR) solutions.
Disappointing manufacturing data in China weighed down shares of Alibaba (NYSE: BABA).
Crude oil prices retreated to send shares of Petrobras (NYSE: PBR) lower.
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 eased a fraction to 1,942. Bitcoin added $1 to $229.